Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adma, Aprea, Astellas, Celltrion, Delta-Fly, Formycon, Lexicon, Mesoblast, Novo Nordisk, Pfizer, Regeneron, Transthera, Travere, Viatris.